Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol dose A; Drug: Indacaterol dose B; Drug: Indacaterol dose C; Drug: Indacaterol dose D; Drug: Placebo; Drug: Salmeterol
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Familial Mediterranean Fever
Intervention: Drug: Canakinumab
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Acromegaly
Interventions: Drug: Octreotide acetate LAR; Drug: Sandostatin LAR ® (octreotide acetate LAR) 30 MG
Sponsor: L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Not yet recruiting - verified March 2010
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Interventions: Drug: TOBI; Drug: Placebo to TOBI
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: P. Falciparum Malaria
Interventions: Drug: artemether-lumefantrine; Drug: Dihydroartemisinin-piperaquine
Sponsor: Centers for Disease Control and Prevention
Not yet recruiting - verified March 2010
Conditions: Hypertension; Ankle Edema
Interventions: Drug: Aliskiren/amlodipine; Drug: Amlodipine
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Conditions: Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma
Intervention: Drug: panobinostat, bortezomib, dexamethasone
Sponsor: Novartis
Not yet recruiting - verified March 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Indacaterol dose; Drug: Placebo; Drug: Salmeterol
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Renal Interstitial Fibrosis
Interventions: Drug: Everolimus + enteric-coated mycophenolate sodium + Steroids; Drug: Cyclosporine A+EC-MPA+steroids
Sponsor: Novartis
Recruiting - verified March 2010
Condition: Healthy Volunteers
Intervention: Drug: Cyclosporine Capsules USP (Modified) 100 mg
Sponsor: Panacea Biotec Ltd
Completed - verified March 2010
Condition: Healthy Volunteers
Intervention: Drug: Cyclosporine Capsules USP (Modified) 100 mg
Sponsor: Panacea Biotec Ltd
Completed - verified March 2010
Condition: Multiple Myeloma
Interventions: Drug: zoledronic acid; Other: No treatment control
Sponsors: PETHEMA Foundation; Dynamic Solutions S.L. (Contract Research Organization); Novartis Farmacéutica S.A
Not yet recruiting - verified March 2010
Conditions: Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia
Intervention: Drug: Nilotinib
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Imatinib Mesylate; Drug: Docetaxel
Sponsors: M.D. Anderson Cancer Center; Novartis
Active, not recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol; Drug: Placebo
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Wound Infection
Interventions: Drug: Daptomycin; Drug: Cefuroxime
Sponsors: Hannover Medical School; Novartis
Recruiting - verified March 2010
Condition: Chronic Plaque-type Psoriasis
Interventions: Drug: AIN457; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Stage II Hypertension
Interventions: Drug: Aliskiren/Amlodipine/Hydrochlorothiazide; Drug: Aliskiren/Amlodipine
Sponsor: Novartis
Not yet recruiting - verified February 2010
Condition: AML
Intervention: Drug: RAD 001
Sponsors: Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS; Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Myopia
Interventions: Device: Focus DAILIES toric contact lens; Device: Biomedics Toric contact lens
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Advanced Malignancies
Intervention: Drug: INCB028060
Sponsors: Incyte Corporation; Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Urothelial Carcinoma
Interventions: Drug: Docetaxel; Drug: ASA404
Sponsors: Hoosier Oncology Group; Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
All Categories ... by Company » ... Novartis 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
